Megan Timmins's most recent trade in Rockwell Medical Inc was a trade of 15,000 Common Stock done . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc | Megan Timmins | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2026 | 15,000 | 31,240 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Megan Timmins | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 14 Mar 2026 | 3,667 | 162,408 (0%) | 0% | 0.9 | 3,300 | Common Stock |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 97,500 | 166,075 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 97,500 | 97,500 | - | - | Performance-based restricted stock units | |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.70 per share. | 14 Mar 2025 | 3,666 | 71,712 (0%) | 0% | 1.7 | 6,232 | Common Stock |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 14 Mar 2025 | 3,137 | 68,575 (0%) | 0% | 1.8 | 5,552 | Common Stock |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.40 per share. | 17 Mar 2024 | 3,137 | 75,378 (0%) | 0% | 1.4 | 4,392 | Common Stock |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 70,780 | 70,780 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2024 | 50,000 | 78,515 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 37,210 | 37,210 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | Megan Timmins | EVP, CLO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 28,515 | 28,515 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Megan Timmins | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) |